Search Within

Andrew Jeffrey Dunbar

  1. "Sloan Kettering Institute Postdocs"
Formats
  1. Journal Article (8)
  2. Meeting Abstract (5)
  3. Research Letter (1)
Groups
  1. Center for Hematologic Malignancies (14)
  2. Department of Medicine (14)
  3. Hematologic Malignancies, Division of (14)
  4. Sloan Kettering Institute Postdocs (14)
  5. Adult Leukemia (13)
  6. Executive Committee, Center for Hematologic Malignancies (13)

More Groups

People
  1. Ross Levine (13)
  2. Sheng Cai (8)
  3. Sean Devlin (7)
  4. Wenbin Xiao (7)
  5. Erin McGovern (6)
  6. Jacob Glass (6)

More People

Years
  1. 2024 (4)
  2. 2023 (2)
  3. 2022 (1)
  4. 2021 (1)
  5. 2020 (2)
  6. 2019 (2)

More Years

Publications
  1. Blood (7)
  2. Haematologica (2)
  3. American Journal of Hematology (1)
  4. Cancer Cell (1)
  5. Cancer Discovery (1)
  6. Clinical Cancer Research (1)

More Publications

Publishers
  1. American Society of Hematology (7)
  2. American Association for Cancer Research (2)
  3. Ferrata Storti Foundation (2)
  4. Cell Press (1)
  5. John Wiley & Sons, Inc. (1)
  6. Nature Publishing Group (1)

Results (14)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Extended mutational profiling by MSK-IMPACT™ identifies mutations predicting thromboembolic risk in patients with solid tumor malignancy
    Meeting Abstract

    Dunbar, A.; Bolton, K.; Devlin, S. M.; Sanchez-Vega, F.; Gao, J.; Mones, J. V.; Wills, J. M.; Kelly, D.; Farina, M.; Kishore, S.; more...
    Blood (2019)

    Fulltext@MSK | Save
  • Loss of plasmacytoid dendritic cell differentiation is highly predictive for post-induction measurable residual disease and inferior outcomes in acute myeloid leukemia
    Journal Article

    Xiao, W.; Goldberg, A. D.; Famulare, C. A.; Devlin, S. M.; Nguyen, N. T.; Sim, S.; Kabel, C. C.; Patel, M. A.; McGovern, E. M.; Patel, A.; more...
    Haematologica (2019)

    Fulltext@MSK | Save
  • Loss of plasmacytoid dendritic cell differentiation is highly predictive for persistent measurable residual disease and poor outcomes in acute myeloid leukemia
    Meeting Abstract

    Xiao, W.; Goldberg, A. D.; Famulare, C.; Delvin, S.; Patel, M.; McGovern, E.; Patel, A.; Schulman, J.; Dunbar, A.; Epstein-Peterson, Z. D.; more...
    Blood (2018)

    Fulltext@MSK | Save
  • Molecular predictors and current management of minimal residual disease (MRD) following induction chemotherapy for acute myeloid leukemia (AML)
    Meeting Abstract

    Goldberg, A. D.; Famulare, C.; Devlin, S. M.; Farnoud, N.; Menghrajani, K.; Patel, M.; Cai, S.; Dunbar, A.; Epstein-Peterson, Z. D.; McGovern, E.; more...
    Blood (2018)

    Fulltext@MSK | Save